Factors shaping the future of STI include the unequal effects of the COVID-19 crisis on R&D across sectors, the accelerated adoption of digital tools and techniques, and changes in the openness, inclusiveness and agility of research and innovation ecosystems.
Factors shaping the future of STI include the unequal effects of the pandemic on R&D across sectors, the accelerated adoption of digital tools and techniques, and changes in the openness, inclusiveness and agility of research and innovation ecosystems.
This brief discusses the obstacles in developing international clinical trials that are critical to fight the COVID-19 pandemic. It provides information on relevant adaptations of regulatory requirements for clinical trials intended to accelerate processes, and highlights the need to further harmonise these regulations between national regulatory authorities.
The recent growth in the space sector has generated unprecedented levels of entrepreneurship and start-up activity, but the COVID-19 crisis could reverse this positive trend. Space agencies and other public administrations therefore need to fully consider vulnerable smaller actors in their overall crisis responses.
The urgency of tackling COVID-19 has led governments in many countries to launch a number of short-notice and fast-tracked initiatives. Yet without proper co-ordination amongst ministries and agencies, they run the risk of duplicating efforts or missing opportunities, resulting in slower progress and economic inefficiencies.
Governments can deploy non-traditional approaches to science, technology and innovation policy making that draw on society’s collective intelligence to find solutions to the COVID-19 crisis. Tools such as innovation prizes, prediction markets, and open-source solutions have shown value and are well-suited to immediately respond to the crisis.
In global emergencies like the COVID-19 pandemic, open science policies can remove obstacles to the free flow of research data and ideas, and thus accelerate the pace of research critical to combating the disease.
While individual experts are often responsible for communicating science advice, they must be guided by clear common principles and supported by scientific institutions and networks across the globe. This requires international co-operation and open sharing of data and information.
Disclosures of personal information can allow the public to better identify potential COVID-19 infections and track the spread over time. However, current digital solutions for monitoring and containment have varying implications for privacy and data protection.
English, PDF, 620kb
Digitalisation is reshaping all stages of science, from agenda setting to experimentation, knowledge sharing and public engagement.